MarketBeat Instant News Alerts 2 hours agoOmniAb Highlights $3B Milestone Pipeline, AI Antibody Platform at ConferenceMarketBeatOmniAb (NASDAQ:OABI) Chief Financial Officer Kurt Gustafson outlined the company’s antibody-discovery platform, partner pipeline and revenue model during a company presentation, emphasizing a strategy built around licensing technology to pharmaceutical and biotechnology companies rather than developNASDAQ:OABIRead OmniAb Highlights $3B Milestone Pipeline, AI Antibody Platform at Conference3 hours agoFitLife Brands Eyes Acquisitions, Margin Gains to Offset Organic Growth HeadwindsMarketBeatFitLife Brands (NASDAQ:FTLF) outlined its strategy to grow a portfolio of nutritional supplement and wellness brands through acquisitions, e-commerce sales and operational improvements, while acknowledging recent organic-growth headwinds tied to Amazon changes, specialty retail traffic and weakeningNASDAQ:FTLFRead FitLife Brands Eyes Acquisitions, Margin Gains to Offset Organic Growth Headwinds4 hours agoStrawberry Fields REIT CEO Maps SNF Growth Strategy, 100% Rent Collection RecordMarketBeatStrawberry Fields REIT (NYSEAMERICAN:STRW) Chairman, CEO and founder Moishe Gubin outlined the skilled nursing facility real estate investment trust’s growth strategy, lease structure and demographic outlook, emphasizing recurring rent collections and a disciplined acquisition model. Gubin said theNYSEAMERICAN:STRWRead Strawberry Fields REIT CEO Maps SNF Growth Strategy, 100% Rent Collection RecordOctober 24, 2026 5:02 PM ETAmgen's IMDELLTRA Cuts Death Risk 58% in Small-Cell Lung Cancer StudyMarketBeatAmgen (NASDAQ:AMGN) presented Phase III data at the European Society for Medical Oncology Congress 2026 showing that its DLL3-targeting BiTE therapy IMDELLTRA, when added to durvalumab maintenance treatment, improved survival outcomes for patients with extensive-stage small-cell lung cancer whose diNASDAQ:AMGNRead Amgen's IMDELLTRA Cuts Death Risk 58% in Small-Cell Lung Cancer StudyOctober 24, 2026 4:02 PM ETModerna Melanoma Therapy Cuts Recurrence Risk 42% in Phase 3 TrialMarketBeatModerna (NASDAQ:MRNA) presented Phase 3 results for intismeran, its individualized neoantigen therapy, in combination with Merck’s pembrolizumab for patients with resected high-risk melanoma. The INTerpath-001 trial met its primary endpoint of relapse-free survival and a key secondary endpoint of diNASDAQ:MRNARead Moderna Melanoma Therapy Cuts Recurrence Risk 42% in Phase 3 TrialOctober 24, 2026 3:02 PM ETParabilis Highlights 72% Response Rate, Maps Phase III Desmoid Trial for 2027MarketBeatParabilis Medicines (NASDAQ:PBLS) presented updated interim phase I/II data for investigational beta-catenin/TCF inhibitor zolucatetide in desmoid tumors at the European Society for Medical Oncology Congress in Madrid, reporting tumor responses, disease control and an FDA-aligned plan for a registraNASDAQ:PBLSRead Parabilis Highlights 72% Response Rate, Maps Phase III Desmoid Trial for 2027 Trending News1Cerebras Systems (NASDAQ:CBRS) Stock Falls 2% Following Analyst Downgrade2Archer Aviation Inc. (NYSE:ACHR) Stock Has Consensus Price Target of $11.003BigBear.ai (BBAI) Projected to Release Earnings on Tuesday4Cerebras Systems Inc. $CBRS Stock Position Increased by ICG Advisors LLC5What SpaceX (SPCX) Said on Its Q3 Earnings Call6Advanced Micro Devices (NASDAQ:AMD) Stock Gets Price Target Boost from Susquehanna7Lucid Group (NASDAQ:LCID) Stock Jumps 5.5% - Here's What Happened8Scotiabank Issues Pessimistic Forecast for TELUS (TSE:T) Stock Price All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords More filters Fewer filters Done October 24, 2026 2:30 PM ETStrategy Inc Variable Rate Series A Perpetual Stretch Preferred Stock (NASDAQ:STRC) Plans Dividend of $0.03MarketBeatNASDAQ:STRCRead Strategy Inc Variable Rate Series A Perpetual Stretch Preferred Stock (NASDAQ:STRC) Plans Dividend of $0.03October 24, 2026 2:02 PM ETCitroTech Targets Wildfire Defense Growth With Hexion JV, CitroSafe PushMarketBeatNYSEAMERICAN:CITRRead CitroTech Targets Wildfire Defense Growth With Hexion JV, CitroSafe PushOctober 24, 2026 1:08 PM ETAutoCanada (TSE:ACQ) Stock: Insider Paul Antony Acquires 5,000 SharesMarketBeatTSE:ACQRead AutoCanada (TSE:ACQ) Stock: Insider Paul Antony Acquires 5,000 SharesOctober 24, 2026 1:02 PM ETPromising Home Improvement Stocks To Follow Now - October 24thMarketBeatNYSE:HDRead Promising Home Improvement Stocks To Follow Now - October 24thOctober 24, 2026 1:02 PM ETTravel Stocks To Add to Your Watchlist - October 24thMarketBeatNASDAQ:BKNGRead Travel Stocks To Add to Your Watchlist - October 24thOctober 24, 2026 1:02 PM ETTop Streaming Stocks To Keep An Eye On - October 24thMarketBeatNYSE:SPOTRead Top Streaming Stocks To Keep An Eye On - October 24thOctober 24, 2026 1:02 PM ETBest Robotics Stocks To Follow Today - October 24thMarketBeatNASDAQ:TERRead Best Robotics Stocks To Follow Today - October 24thOctober 24, 2026 1:02 PM ETBest Infrastructure Stocks To Keep An Eye On - October 24thMarketBeatNASDAQ:MRVLRead Best Infrastructure Stocks To Keep An Eye On - October 24thOctober 24, 2026 1:02 PM ETBest Waste Management Stocks Worth Watching - October 24thMarketBeatNYSE:WMRead Best Waste Management Stocks Worth Watching - October 24thOctober 24, 2026 1:02 PM ETLuxury Goods Stocks To Follow Today - October 24thMarketBeatNYSE:NKERead Luxury Goods Stocks To Follow Today - October 24thOctober 24, 2026 1:02 PM ETPromising Water Stocks To Follow Today - October 24thMarketBeatNYSE:KORead Promising Water Stocks To Follow Today - October 24thOctober 24, 2026 1:02 PM ETFintech Stocks To Watch Now - October 24thMarketBeatNYSE:RKTRead Fintech Stocks To Watch Now - October 24thOctober 24, 2026 1:02 PM ETValue Stocks To Keep An Eye On - October 24thMarketBeatNASDAQ:QQQRead Value Stocks To Keep An Eye On - October 24thOctober 24, 2026 1:02 PM ETBest Dividend Stocks To Research - October 24thMarketBeatNYSE:VZRead Best Dividend Stocks To Research - October 24thOctober 24, 2026 1:02 PM ETPromising Large Cap Stocks To Add to Your Watchlist - October 24thMarketBeatNASDAQ:QQQRead Promising Large Cap Stocks To Add to Your Watchlist - October 24thOctober 24, 2026 12:02 PM ETLotus Technology Targets EBIT Profitability Before 2030 as Deliveries, Margins ImproveMarketBeatNASDAQ:LOTRead Lotus Technology Targets EBIT Profitability Before 2030 as Deliveries, Margins ImproveOctober 24, 2026 12:02 PM ETTop Ecommerce Stocks Worth Watching - October 24thMarketBeatNASDAQ:WMTRead Top Ecommerce Stocks Worth Watching - October 24thOctober 24, 2026 12:02 PM ETGrocery Stocks To Watch Now - October 24thMarketBeatNASDAQ:CARTRead Grocery Stocks To Watch Now - October 24thOctober 24, 2026 12:02 PM ETPromising Restaurant Stocks To Keep An Eye On - October 24thMarketBeatNYSE:MCDRead Promising Restaurant Stocks To Keep An Eye On - October 24thOctober 24, 2026 12:02 PM ETAgriculture Stocks To Watch Today - October 24thMarketBeatNYSE:DERead Agriculture Stocks To Watch Today - October 24thOctober 24, 2026 12:02 PM ETBest Music Stocks To Follow Now - October 24thMarketBeatNASDAQ:NTESRead Best Music Stocks To Follow Now - October 24thOctober 24, 2026 12:02 PM ETVirtual Reality Stocks To Watch Now - October 24thMarketBeatNASDAQ:METARead Virtual Reality Stocks To Watch Now - October 24thOctober 24, 2026 12:02 PM ETPromising Video Game Stocks To Keep An Eye On - October 24thMarketBeatNASDAQ:TBCHRead Promising Video Game Stocks To Keep An Eye On - October 24thOctober 24, 2026 12:02 PM ETBest Toy Stocks To Follow Today - October 24thMarketBeatNASDAQ:HASRead Best Toy Stocks To Follow Today - October 24th Featured Articles and OffersThese 3 Green Stocks Have a Growth Story That Goes Far Beyond WashingtonBy Chris Markoch | October 18, 2026Trump's New DollarFrom Porter & Company (Ad)Tesla's Roadster Reveal Hints at 2 Much Bigger MovesBy Sam Quirke | October 19, 2026Aurora Rejects Curaleaf's Higher Bid, But the Takeover Fight Isn't OverBy Jeffrey Neal Johnson | October 20, 2026Is Texas Instruments Setting Up for Its Next Big Breakout?By Thomas Hughes | October 22, 2026A letter from Shannon StansberryFrom Porter & Company (Ad)GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?By Ryan Hasson | October 21, 2026The AI Sell-Off Continues—These 3 Stocks Keep Raising Guidance AnywayBy Bridget Bennett | October 19, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 364 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
